Update in therapeutic strategies for Parkinson's disease


Por: Kulisevsky, J, Oliveira, L, Fox, SH

Publicada: 1 ago 2018
Resumen:
Purpose of review To review recent advances in therapeutics for motor and nonmotor symptoms of Parkinson's disease. Recent findings Neuroprotection remains a large area of investigation with preliminary safety data on alpha synuclein immunotherapy and glucagon-like peptide-1 agonists. Novel Monoamine Oxidase B and Caetchol-O-methyltransferase-inhibitors for motor fluctuations have shown benefit and are recently approved for clinical use. Long-acting amantadine has also been approved to reduce dyskinesia. Alternative delivery strategies (sublingual, inhaled) dopaminergics may prove useful for rapid reversal of Parkinson's disease motor symptoms. Advanced therapies (surgery and infusional therapies) continue to be useful in subgroups of patients for motor complications with improved safety and also benefit on some nonmotor symptoms, including neuropsychiatric issues. Specific therapeutics for cognition, swallowing, sleep, and mood disorders had moderate to limited benefits. Exercise-based therapy appears beneficial at all stages of Parkinson's disease. Summary The motor symptoms of Parkinson's disease can be reasonably treated and managed. However, therapies to slow or prevent disease progression remain a focus of research. Despite increased studies, treating nonmotor symptoms remains a challenge and an ongoing priority.

Filiaciones:
Kulisevsky, J:
 Univ Autonoma Barcelona, Movement Disorders Unit, Dept Neurol, Sant Pau Hosp IIB St Pau, Barcelona, Spain

 Univ Oberta Catalunya, CIBERNED, Barcelona, Spain

Oliveira, L:
 Univ Hlth Network, Edmond J Safra Program Parkinsons Dis, Toronto Western Hosp, Toronto, ON, Canada

 Univ Hlth Network, Morton & Gloria Shulman Movement Disorders Clin, Toronto Western Hosp, 399 Bathurst St, Toronto, ON M5T 2S8, Canada

Fox, SH:
 Univ Hlth Network, Edmond J Safra Program Parkinsons Dis, Toronto Western Hosp, Toronto, ON, Canada

 Univ Hlth Network, Morton & Gloria Shulman Movement Disorders Clin, Toronto Western Hosp, 399 Bathurst St, Toronto, ON M5T 2S8, Canada
ISSN: 13507540





CURRENT OPINION IN NEUROLOGY
Editorial
LIPPINCOTT WILLIAMS & WILKINS, TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA, Estados Unidos America
Tipo de documento: Review
Volumen: 31 Número: 4
Páginas: 439-447
WOS Id: 000455659300012
ID de PubMed: 29746402

MÉTRICAS